Cardiac Nitric Oxide Synthase 1 Regulates Basal and β-Adrenergic Contractility in Murine Ventricular Myocytes

Publisher Website
Google Scholar
Abstract
Background— Evidence indicates that myocardial NO production can modulate contractility, but the source of NO remains uncertain. Here, we investigated the role of a type 1 NO synthase isoform (NOS1), which has been recently localized to the cardiac sarcoplasmic reticulum, in the regulation of basal and β-adrenergic myocardial contraction. Methods and Results— Contraction was assessed in left ventricular myocytes isolated from mice with NOS1 gene disruption (NOS1−/− mice) and their littermate controls (NOS1+/+ mice) at 3 stimulation frequencies (1, 3, and 6 Hz) in basal conditions and during β-adrenergic stimulation with isoproterenol (2 nmol/L). In addition, we examined the effects of acute specific inhibition of NOS1 with vinyl-l-N-5-(1-imino-3-butenyl)-l-ornithine (L-VNIO, 500 μmol/L). NOS1−/− myocytes exhibited greater contraction at all frequencies (percent cell shortening at 6 Hz, 10.7±0.92% in NOS1−/− myocytes versus 7.21±0.8% in NOS1+/+ myocytes; P−/− myocytes at all frequencies (at 6 Hz, 26.53±1.4 ms in NOS1−/− myocytes versus 21.27±1.3 ms in NOS1+/+ myocytes; P+/+ myocytes versus 26.45±1.4 ms in NOS1+/++L-VNIO myocytes; P−/− myocytes and NOS1+/+ myocytes treated with L-VNIO showed a greatly enhanced contraction in response to β-adrenergic stimulation (percent increase in contraction at 6 Hz, 25.2±10.8 in NOS1+/+ myocytes, 68.2±11.2 in NOS1−/− myocytes, and 65.1±13.2 in NOS1+/++L-VNIO myocytes; PConclusions— NOS1 disruption enhances basal contraction and the inotropic response to β-adrenergic stimulation in murine ventricular myocytes. These findings indicate that cardiac NOS1-derived NO plays a significant role in the autocrine regulation of myocardial contractility.